With my eyes going back and forth between your list and the 10K:
Sandoz has Finland, Denmark, and Norway
Recordati owns Ireland and Portugal, and has a lock on eastern Europe that would include Poland, Slovakia and Czech
Ferring has all of Latin America that would include Mexico
Elis licensed Gulf countries and the non-Israeli ME that would include Kuwait, Lebanon, Saudi Arabia and UAE
Of your list of thirteen, five have approved Vitaros per the 10K including Ireland and Portugal with Recordati and Finland, Denmark, and Norway with Sandoz. So the remaining eight countries on your list have a ways to go before launching.
NOTE, the corporate presentation states that Vitaros has been "Approved in 22 countries in Europe under the DCP, of which 17 have further approved Vitaros for commercialization at the national phase level"...however where is the list of the 17 that are ready for commercialization implying ready to launch?
I think the biggie on your list is Mexico which will open up Latin America. Unfortunately, Latin America will probably wait for the FDA, which is another reason why FDA approval is so important. I hope Mexico is ready to launch and its inclusion was not just a sloppy statement in the presentation. |
